Cargando…
Comparison of the efficacy and safety of moclobemide and imipramine in the treatment of depression in Indian patients
BACKGROUND: Moclobemide, a benzamide, is one of the new-generation monoamine oxidase-A inhibitors (MAO-AIs) which belongs to the class of reversible inhibitors of monoamine oxidase (RIMA). Numerous studies have shown that moclobemide is well-tolerated and as effective as other antidepressants. So fa...
Autores principales: | Avasthi, Ajit, Kulhara, Parmanand, Singh, Gagandeep, Sharma, Rajni, Kaur, Rajinder P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918305/ https://www.ncbi.nlm.nih.gov/pubmed/20711287 http://dx.doi.org/10.4103/0019-5545.55951 |
Ejemplares similares
-
Seasonality in affective disorders using SPAQ
por: Avasthi, Ajit, et al.
Publicado: (2003) -
RESPONSE TO FIRST ECT IN DEPRESSION : A PREDICTOR OF OUTCOME
por: Gupta, Nitin, et al.
Publicado: (1998) -
Metabolic Syndrome in Drug-naïve Patients with Depressive Disorders
por: Grover, Sandeep, et al.
Publicado: (2013) -
OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA : AN OPEN LABEL COMPARATIVE CLINICAL TRIAL FROM NORTH INDIA
por: Avasthi, Ajit, et al.
Publicado: (2001) -
COMPARISON OF THE EXTENT AND PATTERN OF FAMILY BURDEN IN AFFECTIVE DISORDERS AND SCHIZOPHRENIA
por: Chakrabarti, Subho, et al.
Publicado: (1995)